
Sign up to save your podcasts
Or


In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about upadacitinib, a new treatment for giant-cell arteritis; growing evidence linking oral health to a higher risk of neurologic conditions; and why a trial of a new meningitis B vaccine drew a mixed response.
By American Academy of Neurology4.7
1919 ratings
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about upadacitinib, a new treatment for giant-cell arteritis; growing evidence linking oral health to a higher risk of neurologic conditions; and why a trial of a new meningitis B vaccine drew a mixed response.

137 Listeners

323 Listeners

499 Listeners

296 Listeners

46 Listeners

13 Listeners

192 Listeners

93 Listeners

514 Listeners

136 Listeners

368 Listeners

190 Listeners

375 Listeners

6 Listeners

83 Listeners